Attention-deficit / Hyperactivity Disorder (ADHD)
Conditions
Interventions
60 subjects with ADHD receive 30 sessions EEG-neurofeedback, 60 subjects with
ADHD receive placebo EEG-neurofeedback.
Sponsors
Universitair Medisch Centrum Sint Radboud
Eligibility
Age
2 Years to 17 Years
Inclusion criteria
Inclusion criteria: Diagnosis ADHD (classified by the DSM-IV TR) Age between 8 and 15 A full scale IQ ³ 80 Medication- naïve, or using psychostimulants/atomoxetine but still with room for improvement
Exclusion criteria
Exclusion criteria: Currently intensive (i.e. weekly) individual or group psychotherapy. Use of medication other than psychopharmaca Diagnosis of one or more of the following comorbid psychiatric disorders: Major depression or dysthymie Anxiety disorder Bipolar disorder Psychotic disorder Chronical motor tic disorder or Gilles de la Tourette Conduct disorder Autism spectrum disorders Eating disorders Cardiovascular disease currently/in the past Neurological disorders (e.g. epilepsy) currently or in the past Participation in another clinical trial simultaneously Neurofeedback training in the past Metal parts in body
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ADHD-DSM-IV rating scale, rated by the investigator | — |
Secondary
| Measure | Time frame |
|---|---|
| scores on all neuropsychological tasks absolute en relative power of 4 frequenties EEG bands fluctuations in de BOLD signals on fMRI measures on the diffusion Tensor Imaging (DTI) | — |
Countries
Netherlands
Outcome results
None listed